AGIO

NASD Agios Pharmaceuticals, Inc.
Oct 8, 2026 · 8:56 AM ET LAST TRADE Market Closed

$32.00 ↑ +0.21 (+0.66%) Trading Up from the previous close of $31.79

YTD change
+17.56%
vs 20-day SMA
-3.10%
vs 200-day SMA
+2.88%

Price ranges

Previous day
$31.07 $32.27
open $31.37 close $31.79
+$0.42 (+1.34%)
Today
$0.00 $0.00
$32.00
Past week
$30.78 $33.73
from $33.25 now $32.00
-$1.25 (-3.76%)
Past month
$30.78 $35.36
from $34.63 now $32.00
-$2.63 (-7.59%)
This year
$24.29 $44.09
from $27.22 now $32.00
+$4.78 (+17.56%)

Price & Performance

-1.98 (-5.86%) / 6M

$22.86$30.43$38.01$45.58Apr 8Jul 9Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 67.9% away from all-time highs of $99.82
  • AGIO is up 18% since the beginning of the year
  • AGIO is down 25% over the past 12 months
  • AGIO is down 8% over the past 1 month
  • 13% of all AGIO investors are betting against AGIO

AGIO reads neutral: price sits above one of the two key moving averages, the 12-month move is -25.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.69
Earnings momentum -38.5% Quarterly EPS growth
Quarterly change -38.5%

Valuation

P/E ratio N/A
Enterprise value $1.3B
Beta 1.23

Balance sheet & scale

IncomeN/A
Revenue$98.3M
Cash$617.6M
Debt$31.2K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.9B

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $413.08 +2.60%
MRNA Moderna, Inc. $196.48 +4.81%
RVMD Revolution Medicines, Inc. $200.87 +0.50%
ROIV Roivant Sciences Ltd. $34.75 -2.20%
BNTX BioNTech SE Sponsored ADR $95.25 -0.50%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.